MME and neoplasm: While both NEP inhibitors induced significant and CCK2R-specific tumor uptake enhancement even at the lowest administered doses (1.5 μg TO and 3 μg PA), PA showed consistently superior efficacy at all tested dose levels compared to TO (P < 0.001).